Production (Stage)
BioSyent Inc.
RX.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 23.22% | 8.06% | -3.46% | 4.60% | 50.98% |
| Total Depreciation and Amortization | 68.70% | 1,153.13% | -10.13% | 10.03% | 4.53% |
| Total Amortization of Deferred Charges | -- | -99.42% | 177.78% | -28.57% | -- |
| Total Other Non-Cash Items | 109.59% | 175.38% | -82.04% | 39.02% | -247.61% |
| Change in Net Operating Assets | -334.51% | 189.07% | 36,384.88% | -291.17% | 71.99% |
| Cash from Operations | -170.63% | 276.92% | 169.58% | -148.29% | 187.29% |
| Capital Expenditure | -504.35% | 25.08% | 26.53% | -106.90% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 260.08% | 299.91% | -413.44% | 284.27% | -69.66% |
| Cash from Investing | 257.41% | 193.62% | -407.59% | 284.61% | -69.99% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.56% | -5.43% | -5.50% | -5.31% | -4.90% |
| Issuance of Common Stock | -- | 142.45% | -- | -- | -- |
| Repurchase of Common Stock | 39.37% | -361.21% | 96.23% | 75.17% | -101.41% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.98% | -5.53% | -8.42% | -5.78% | -8.64% |
| Other Financing Activities | 16.03% | 14.63% | 14.12% | 13.29% | 11.86% |
| Cash from Financing | 33.88% | -217.05% | 52.06% | 55.88% | -63.35% |
| Foreign Exchange rate Adjustments | -600.00% | 119.95% | -134.68% | -98.15% | -99.55% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.26% | 61.38% | 163.10% | 61.43% | 36.09% |